SN.L - Smith & Nephew plc
| Previous close | 1,376.00 |
| Open | 1,384.00 |
| Bid | 1,392.00 x 240300 |
| Ask | 1,392.50 x 53000 |
| Day's range | 1,384.00 - 1,393.00 |
| 52-week range | 1,173.00 - 1,442.00 |
| Volume | 152,722 |
| Avg. volume | 3,785,924 |
| Market cap | 12.173B |
| Beta | 0.25 |
| PE ratio (TTM) | 15.88 |
| EPS (TTM) | 87.70 |
| Earnings date | 8 Feb 2018 - 13 Feb 2018 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 18.48 |
- Simply Wall St.•20 days ago
Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?
The size of Smith & Nephew plc (LSE:SN.), a UK£11.91B large-cap, often attracts investors seeking a reliable investment in the stock market. Big corporations are much sought after by risk-averseRead More...
- Fool.co.uk•21 days ago
2 FTSE 100 stocks I’d buy in June
These two FTSE 100 (INDEXFTSE:UKX) stocks have outstanding long-term growth prospects, says G A Chester.
- Reuters - UK Focus•2 months ago
BUZZ-Top of the Street: BBVA, Standard Life Aberdeen, Commerzbank
A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** "Too cheap to ignore," UBS says about BBVA and ups the bank to "buy", also pointing to earnings ...
- Reuters - UK Focus•2 months ago
Smith & Nephew, financials knock FTSE off 3-month high
Britain's top share index slipped on Thursday as a tumble in Smith & Nephew's shares and weakness across financials and health stocks dragged the FTSE 100 off a three-month high. Despite a firmer start to trading and a weaker pound, the blue chip FTSE 100 turned lower and ended the session down 0.54 percent at 7,502.69 points, only slightly outperforming a negative European market.
Sky News•2 months agoWhy the flu season has helped leave Smith & Nephew feeling cold
With (Other OTC: WWTH - news) the population ageing in most rich countries round the world, these should in theory be bumper times for Smith & Nephew (Frankfurt: 502816 - news) , Europe's largest maker of artificial knees, shoulders and hips. It's a disappointing last trading update for Olivier Bohuon, who steps down as chief executive on Monday, although in his defence, the Frenchman - a pharmacy graduate - can point out that he has doubled the share price since he took the job in 2011. One is that Smith & Nephew is seeing weakness in a product area for which it is slightly less well-known - advanced wound management, which supplies ointments, bandages and dressings to healthcare suppliers.
- MarketWatch•2 months ago
FTSE 100 breaks 5-day win streak as investors weigh Fed’s next move
U.K. stocks dropped Thursday, following a five-session winning streak for the blue-chip market, with the focus on the U.S. Federal Reserve decision and its flagging of stronger inflation. Stocks were little changed after a reading on British services activity missed expectations. Shares of Smith & Nephew posted the biggest loss in London after a revenue warning.
Reuters•2 months agoEuropean shares retreat as trade worries weigh on Wall Street
By Danilo Masoni and Julien Ponthus MILAN/LONDON (Reuters) - European bourses closed in negative territory on Thursday at the end of a session laden with corporate earnings and as worries over global trade ...
- Fool.co.uk•2 months ago
I’d happily buy FTSE 100 stock Smith & Nephew despite this chilling news
Royston Wild explains why Smith & Nephew plc (LON: SN) remains a white-hot FTSE 100 (INDEXFTSE: UKX) growth stock.
- Reuters - UK Focus•2 months ago
GLOBAL MARKETS-Trade worries keep world stocks subdued, dollar holds gains
World stocks made little progress on Thursday as worries over global trade tensions weighed, while the U.S. dollar consolidated recent bumper gains after the Federal Reserve reaffirmed the outlook for more rate hikes. Europe's pan-European STOXX 600 index was down 0.3 percent as the euro held firm. In Europe, earnings disappointments from medical technology company Smith & Nephew (Frankfurt: 502816 - news) and postal services provider Bpost (EUREX: BPO.EX - news) soured the mood as the stocks fell 6.3 percent and 10.5 percent respectively, while German drug and crop chemicals maker Bayer (IOB: 0P6S.IL - news) flagged a stronger euro in its update.
- Reuters - UK Focus•2 months ago
LIVE MARKETS-FTSE out of the red as weak data hits pound again
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Danilo Masoni. Reach him on Messenger to share your thoughts on market ...
- Reuters - UK Focus•2 months ago
Commodities help Britain's FTSE outperform while Smith & Nephew tumbles
A strong outlook from miner Glencore and gains in oil stocks provided the bedrock for British shares to outperform stock markets on the continent on Thursday. Mining and energy stocks helped the FTSE stay ...
- Reuters•2 months ago
Outgoing Smith & Nephew CEO signs off with a downgrade
Smith & Nephew downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted. Bohuon, who steps down on Monday, said the business had seen a "mixed performance" in the quarter to end-March, with established markets like the United States and Europe down 2 percent on an underlying basis and emerging markets up 9 percent, resulting in a flat result overall.
- Reuters - UK Focus•2 months ago
Outgoing Smith & Nephew CEO signs off with a downgrade
Smith & Nephew (Frankfurt: 502816 - news) downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted.
- Reuters - UK Focus•2 months ago
European shares dip on heavy earnings day as euro rebounds
European bourses fell in morning trading on Thursday, weighed down by a rebound in the euro and a series of disappointing earning updates including from Smith & Nephew. The pan-European STOXX 600 index ...
- Reuters - UK Focus•2 months ago
BUZZ-Smith & Nephew: guidance cut spurs worst day in 9 years
** Europe's biggest artificial hip and knee maker slumps 6.1 pct, biggest one-day drop since March 2009 ** Co cuts forecast for 2018 underlying revenue growth and profit margin after some markets softened ...
- Reuters - UK Focus•2 months ago
Smith & Nephew downgrades outlook after weak Q1
Smith & Nephew, Europe's biggest artificial hip and knee maker, downgraded its forecast for full-year underlying revenue growth and profit margin after some markets softened and it saw a slowdown in its ...
- The Wall Street Journal•2 months ago
[$$] WPP Chairman Looks to Fill the Gap Left by Sorrell’s Sudden Exit
A little known private-equity executive will steer WPP PLC through one of its stormiest periods following the resignation last weekend of Martin Sorrell.
- Reuters - UK Focus•3 months ago
LIVE MARKETS-Move into defensives paying off
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...
- Reuters - UK Focus•3 months ago
LIVE MARKETS-Mid-session snapshot: STOXX at lows
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...
- Reuters - UK Focus•3 months ago
LIVE MARKETS-Tariffs on U.S. aircraft hit Boeing, boost Airbus
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...
- Reuters - UK Focus•3 months ago
LIVE MARKETS-Trade wars: what's the damage?
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...
- Reuters•3 months ago
Smith & Nephew picks new CEO who sold his last company
Artificial hip and knee maker Smith & Nephew (SN.L), a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making. Namal Nawana, who will replace Olivier Bohuon as CEO of the British company next month, most recently headed medical diagnostics firm Alere, where he oversaw its $5.3 billion sale to Abbott (ABT.N) in 2017. The medical technology firm, which also has wound-care and sports medicine units, is under pressure to improve margins and find new sources of growth as it competes with bigger rivals.
